Patent Licensing FAQ: What Founders Ask Most (And What They Should Be Asking)

Authored by Babak Akhlaghi on July 21, 2026. You spent years building your invention. You invested real money getting the patent. Someone finally wants to license it.

That moment feels like validation. It feels like the finish line.

It’s not. It’s the beginning of a different kind of risk — one that most founders don’t see until it’s too late.

Patent licensing agreements aren’t boilerplate. They’re not like buying a house where the forms are standardized. These agreements are deeply customized, and a single provision can quietly give away rights you didn’t intend to transfer — or leave substantial revenue on the table.

This FAQ covers the questions founders actually ask about patent licensing, and the ones they should be asking but aren’t. It’s grounded in practitioner insights and informed by recent case law, including A.L.M. Holding Co. v. Zydex Industries (Fed. Cir. 2026), which clarified what happens when you license your patent but still need to enforce it.

1. Do I need a patent before I can license my invention?

Technically, no. You can license patent-pending rights or even just know-how.

But here’s the reality: licensees want certainty. A pending application might never issue, or it might issue with claims that don’t cover what the licensee actually wants to commercialize. Most sophisticated licensees won’t commit serious resources until they see an issued patent with defined claim scope.

If you’re licensing before issuance, make sure the agreement accounts for what happens if the patent doesn’t issue, or if it issues with narrower claims than expected. Otherwise you’re negotiating terms for rights that might never materialize.

2. What’s the difference between an exclusive and non-exclusive license?

An exclusive license means the licensee is the only party who can practice the patent in the defined field and territory. In many cases, that includes you — the patent owner — unless the agreement explicitly reserves your right to use the invention.

A non-exclusive license lets you grant licenses to multiple parties for the same patent. You can spread risk across partners, and if one underperforms, others may still deliver results. Non-exclusive licenses generate multiple royalty streams but typically command lower rates because the licensee doesn’t get market exclusivity.

💡 Key insight: Exclusive licenses often command higher royalties because the licensee gains competitive advantage and is more likely to invest in commercialization. But exclusivity also concentrates your risk in one partner.

3. Can I still use my own invention after I license it?

It depends entirely on what the grant clause says.

If you grant an exclusive license without reserving your own right to practice the invention, you lose the ability to use it. That’s not a bug — it’s a feature of exclusivity. The licensee wants assurance that you won’t compete with them.

If you want to retain usage rights, you need to explicitly reserve them in the agreement. For example, you might reserve the right to make, use, and sell the invention for research and development purposes, or to sell products containing the licensed technology as long as you purchase components from the licensee.

This isn’t something you figure out later. If it’s not in the grant clause, you don’t have it.

4. What happens if my licensee doesn’t perform?

If the agreement doesn’t have performance milestones, the answer is: nothing happens. You watch them sit on your patent while competitors move forward, and you have no recourse.

A well-drafted agreement includes minimum performance obligations — revenue thresholds, sales targets, or commercialization milestones. If the licensee fails to meet them, the agreement should specify consequences: the exclusive license converts to non-exclusive, or the license terminates entirely.

In the A.L.M. v. Zydex case, the licensing agreement included a minimum annual royalty provision. If the licensee didn’t meet it, the exclusive license would become non-exclusive. That gave the patent owner leverage and a path to monetize the patent through other partners if the original licensee underperformed.

⚠️ Without milestone provisions, you’re hoping the licensee delivers. Hope isn’t a strategy.

5. Can my licensee sublicense my patent to someone else without my permission?

Only if the agreement allows it.

Many licensing agreements grant the licensee the right to sublicense, but you should retain approval rights over any sublicense terms. That approval doesn’t have to be arbitrary — the agreement can specify that consent won’t be unreasonably withheld — but it ensures the licensee can’t sublicense free of your economic and strategic interests.

In A.L.M. v. Zydex, the patent owner retained the right to review and approve sublicenses. The agreement also required that any royalties generated by a sublicensee flow to the patent owner as if the licensee had made the sale directly. This preserved the patent owner’s royalty stream and prevented the licensee from diluting the patent owner’s economic interest through downstream deals.

If your licensee can sublicense without your consent, they can effectively authorize your competitors to practice the patent — and you can’t stop them.

6. What if my licensee doesn’t want to sue an infringer — can I still enforce my patent?

This is where most founders discover they’ve disarmed themselves.

If the licensing agreement gives the licensee exclusive enforcement rights, and the licensee chooses not to sue, you’re stuck. You watch a competitor infringe your patent, erode your market, and you can’t do anything about it.

The licensee’s incentives might be completely different from yours. They might have a business relationship with the infringer. They might not want the legal exposure. They might just not want to spend the money. And you — the person who invented the technology and fought for the patent — have no recourse.

The solution is to retain the right to sue independently. In A.L.M. v. Zydex, the agreement provided that if the licensee chose not to pursue an infringement action, the patent owner could proceed on its own, control the litigation, and collect any resulting damages. That preserved the patent owner’s ability to enforce the patent even when the licensee’s interests diverged.

This isn’t theoretical. It happens. And if it happens once, that’s too many.

7. Does licensing my patent mean I give up the right to sue infringers?

Not necessarily — but it depends on what rights you retain.

The Federal Circuit’s decision in A.L.M. v. Zydex clarified that a patent owner can maintain constitutional standing to sue for infringement even after granting an exclusive license, as long as the owner retains a non-illusory exclusionary right. That can include the right to sue, the right to veto sublicenses, and the right to collect royalties from any sublicensees.

In that case, the district court initially dismissed the patent owner’s infringement suit for lack of standing, reasoning that the exclusive license had transferred away all exclusionary rights. The Federal Circuit reversed, holding that the combination of the retained right to sue, sublicensing approval rights, and royalty interests demonstrated a concrete stake in excluding unauthorized practice of the patents.

The court distinguished this from cases like Morrow v. Microsoft, where the plaintiff held only a bare contractual right to sue, separated from all other patent rights. In Morrow, the patent owner could have mooted any suit by granting a royalty-free sublicense to the accused infringer. That made the right to sue illusory.

Here’s the lesson: retaining the right to sue isn’t enough if the licensee can nullify it through unilateral sublicensing. You need to preserve control over enforcement and economic interests that make the right meaningful.

8. What is the grant clause and why does it matter most?

The grant clause is the heart of the licensing agreement. It defines exactly which patent rights you’re transferring, which ones you’re keeping, and under what conditions.

Every patent issued by the USPTO comes with a bundle of exclusionary rights: the right to make, use, sell, offer to sell, and import the patented invention. You can assign any or all of these rights. You can limit them by field of use, by geographic territory, or by duration.

A precisely drafted grant clause protects both parties. For the licensee, it provides clarity about what they’re acquiring. For you, it preserves your ability to grant licenses to other parties, maintain a competitive position in adjacent markets, or retain freedom to operate.

The grant must be a present grant — it conveys rights now, not a promise to convey them later. And it must be unambiguous. If there’s confusion about what rights were transferred, you’re heading for expensive litigation to resolve it.

💡 Practical tip: The Federal Circuit has confirmed that unless the grant clause says otherwise, the right to “make, use, and sell” a licensed product includes the implied right to have those products made by a third party (the “have made” right). If you want to restrict that, you need to say so explicitly.

9. Should I involve a patent attorney in licensing negotiations, or is that just for prosecution?

If you were prudent enough to protect your invention at the start, you should be prudent enough to protect it at the licensing stage.

Patent licensing agreements are not standardized. A single provision can give away rights you didn’t intend to transfer, or leave substantial revenue on the table. These agreements are deeply personalized, and the stakes are high.

You need a seasoned patent attorney with licensing experience. Not just someone who prosecutes patents, but someone who understands how these agreements function in practice, how courts interpret them, and where the traps are.

The licensing moment feels like validation. It feels like the finish line. It’s not. It’s the moment when you’re most vulnerable to making a mistake that can’t be fixed later.

Slow down. Run the agreement by an attorney before you sign. Make sure the grant clause aligns with your intent. Make sure you’ve retained the rights that matter. Make sure you’ve anticipated the scenario where your interests diverge from the licensee’s — and you’ve preserved your recourse.

10. What does “Article III standing” mean and why should a founder care?

Article III standing is the constitutional requirement that a plaintiff must have suffered a concrete, particularized injury to bring a lawsuit in federal court.

In patent infringement cases, that generally means you need to show that you have an exclusionary right in the patent that’s been harmed. If you’ve transferred away all exclusionary rights through a licensing agreement, you may not have standing to sue — even if someone is infringing your patent.

This isn’t academic. In A.L.M. v. Zydex, the district court dismissed the patent owner’s infringement suit for lack of standing, concluding that the exclusive license had transferred away all exclusionary rights. The Federal Circuit reversed, but only because the patent owner had retained enough control — through the right to sue, sublicensing approval, and royalty interests — to demonstrate a non-illusory stake in enforcement.

If the agreement had been drafted differently — if the licensee could have sublicensed freely, or if the patent owner had no enforcement rights — the outcome would have been different. The patent owner would have been barred from suing, regardless of the merit of the infringement claim.

The takeaway: The way you structure your licensing agreement determines whether you can enforce your patent later. If you give away too much, you lose the ability to protect what you built — not because you lost the patent, but because you lost the right to assert it.

Before You Sign

Patent licensing is where strategy meets contract drafting. The rights you retain, the milestones you set, the enforcement provisions you include — these aren’t just legal formalities. They’re the architecture of your ability to protect and monetize what you’ve built.

Read the agreement carefully. Make sure the grant clause reflects what you actually intend to transfer. Think about the scenario where your interests diverge from the licensee’s, and make sure you’ve preserved your recourse.

And involve a seasoned patent licensing attorney before you sign. If you’ve invested years and real money protecting your invention, don’t give it away in a contract you didn’t fully understand.

The finish line isn’t the patent. It’s not the licensing deal. It’s building something that lasts — and keeping the rights you need to defend it.